
Please try another search
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.
Name | Age | Since | Title |
---|---|---|---|
Kazuto Yamada | - | 2025 | President, CEO & Director |
Takahiro Kato | 56 | 2008 | Audit & Supervisory Board Member |
Toshihiro Osuka | 68 | 2004 | Corporate Officer & Director |
Kaoru Ogawa | 67 | 2017 | Audit & Supervisory Board Member |
Toshiyuki Masai | 73 | 2022 | Independent Outside Non-Executive Director |
Takayuki Nakano | 54 | 2021 | Non-Executive Director |
Yasuo Kitajima | 82 | 2023 | Independent Outside Non-Executive Director |
Yasuhiko Handa | - | 2025 | Audit and Supervisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review